Is a complete RNTX research report available?

No complete published report is available for Rein Therapeutics Inc. (RNTX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Rein Therapeutics Inc. (RNTX)

NASDAQ: RNTX · USD

$0.70

-0.01 (-0.9%)· Recorded snapshot

Market cap	60.2M
Net income (ttm)	-49.8M
EPS (ttm)	-$0.58
Shares out	86.3M
Volume	388,787
Beta	1.36

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -49.8M
EPS (ttm): -$0.58
Market cap: 60.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	احتفاظ

Metric	Value
Amount currency	USD
CIK code	0001420565
Company name	Rein Therapeutics Inc.
Country	United States
Country code	US
CUSIP number	00887A204
Earnings date	2026-11-13
Earnings time	bmo
Employees	10
Employees change	-1
Employees growth	-9.09%
Enterprise value	$19.6M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2001
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US00887A2042
Last 10-K release date	2026-03-26
Last earnings date	2026-08-14
Last refreshed	2026-10-28
Last stock split date	2022-11-11
Last stock split type	Reverse
Market cap	$60.2M
Market cap category	Micro-Cap
Next earnings date	2026-11-13
Options	No
Price	$0.70
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	RNTX
U.S. state	Texas
Website	https://www.reintx.com

Metric

Value

Amount currency

USD

CIK code

0001420565

Company name

Rein Therapeutics Inc.

Country

United States

Country code

CUSIP number

00887A204

Earnings date

2026-11-13

Earnings time

bmo

Employees

Employees change

-1

Employees growth

-9.09%

Enterprise value

$19.6M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2001

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US00887A2042

Last 10-K release date

2026-03-26

Last earnings date

2026-08-14

Last refreshed

2026-10-28

Last stock split date

2022-11-11

Last stock split type

Reverse

Market cap

$60.2M

Market cap category

Micro-Cap

Next earnings date

2026-11-13

Options

Price

$0.70

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

RNTX

U.S. state

Texas

Website

https://www.reintx.com

Metric	Value
Earnings yield	-83.11%
FCF / EV yield	-107.1%
FCF yield	-32.34%
P/B ratio	5.92x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-83.11%

FCF / EV yield

-107.1%

FCF yield

-32.34%

P/B ratio

5.92x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Profit per employee	$-5M
ROA	-21.02%
ROA (5Y)	-33.59%
ROCE	-36.89%
ROE	-96.42%
ROE (5Y)	-85.98%
ROIC	-25.14%

Metric

Value

Profit per employee

$-5M

ROA

-21.02%

ROA (5Y)

-33.59%

ROCE

-36.89%

ROE

-96.42%

ROE (5Y)

-85.98%

ROIC

-25.14%

Metric	Value
EPS growth quarters	6
EPS growth years	1
Net income growth quarters	1
Net income growth years	1
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth years

Metric	Value
Depreciation and amortization	$500
EBIT	$-20.8M
EBITDA	$-20.8M
EPS	$-0.58
FCF per share	$-0.22
Financing cash flow	$56.8M
Free cash flow	$-18.8M
Free cash flow minus SBC	$-20.9M
Income taxes	$-712,000
Investing cash flow	$-35.1M
Net borrowing	$-1.1M
Net cash flow	$2.8M
Net income	$-49.8M
Operating cash flow minus SBC	$-20.9M
Operating income	$-20.8M
Stock-based compensation	$2M

Metric

Value

Depreciation and amortization

$500

EBIT

$-20.8M

EBITDA

$-20.8M

EPS

$-0.58

FCF per share

$-0.22

Financing cash flow

$56.8M

Free cash flow

$-18.8M

Free cash flow minus SBC

$-20.9M

Income taxes

$-712,000

Investing cash flow

$-35.1M

Net borrowing

$-1.1M

Net cash flow

$2.8M

Net income

$-49.8M

Operating cash flow minus SBC

$-20.9M

Operating income

$-20.8M

Stock-based compensation

$2M

Metric	Value
Book value per share	$0.12
Debt / equity	0
Goodwill	$6.3M
Long-term assets	$24.5M
Long-term liabilities	$1.1M
Net cash (debt)	$40.6M
Net cash / market cap	69.8%
Net cash growth	610.36%
Net debt / equity	-0.74
Piotroski F-Score	2
Shareholders' equity	$55.2M
Tangible book value	$-9.6M
Tangible book value per share	$-0.11
Total assets	$66M
Total cash	$40.6M
Total debt	$0
Total liabilities	$10.8M
WACC	11.7%

Metric

Value

Book value per share

$0.12

Debt / equity

Goodwill

$6.3M

Long-term assets

$24.5M

Long-term liabilities

$1.1M

Net cash (debt)

$40.6M

Net cash / market cap

69.8%

Net cash growth

610.36%

Net debt / equity

-0.74

Piotroski F-Score

Shareholders' equity

$55.2M

Tangible book value

$-9.6M

Tangible book value per share

$-0.11

Total assets

$66M

Total cash

$40.6M

Total debt

Total liabilities

$10.8M

WACC

11.7%

Metric	Value
Current assets	$41.5M
Current liabilities	$9.7M
Current ratio	4.27
Net working capital	$-8.9M
Quick ratio	4.19
Working capital	$31.7M

Metric

Value

Current assets

$41.5M

Current liabilities

$9.7M

Current ratio

4.27

Net working capital

$-8.9M

Quick ratio

4.19

Working capital

$31.7M

Metric	Value
Buyback yield / dilution	-283.2%
Dividend yield	0%
Shareholder yield	-283.2%

Metric

Value

Buyback yield / dilution

-283.2%

Dividend yield

Shareholder yield

-283.2%

Metric	Value
150-day SMA	$0.98
1D price change	-0.87%
1M price change	-9.42%
1M total return	-9.42%
1W price change	13.91%
1W total return	13.91%
1Y price change	-49.79%
1Y return CAGR	-49.81%
1Y total return	-49.79%
20-day SMA	$0.70
200-day SMA	$1.04
3M price change	-13.27%
3M total return	-13.27%
3Y price change	-42.55%
3Y return CAGR	-16.87%
3Y total return	-42.55%
50-day SMA	$0.75
50-day SMA vs 200-day SMA	50under200
52-week high	$2.18
52-week high date	2025-11-03
52-week low	$0.54
52-week low date	2026-10-14
5Y price change	-96.14%
5Y return CAGR	-47.84%
5Y total return	-96.14%
6M price change	-54.5%
6M total return	-54.5%
All-time high	$309.60
All-time high date	2017-10-05
All-time low	$0.54
All-time low date	2026-10-14
Average true range (ATR)	$0.07
Average volume	477.2K
Beta (1Y)	1.73
Beta (2Y)	1.44
Beta (5Y)	1.36
Change from 52-week high	-67.98%
Change from 52-week low	29.25%
Change from all-time high	-99.78%
Change from all-time low	25.51%
Change from open	-0.87%
Day's gap	0%
Dollar volume	$271,412
High price	$0.70
Low price	$0.67
Monthly RSI	36.43
Open price	$0.70
Position in 52-week range	82.67%
Premarket change	4.94%
Premarket close	$0.70
Premarket price	$0.74
Premarket volume	17.1K
Previous close	$0.70
Price vs 150-day SMA	-30.59%
Price vs 20-day SMA	-2.6%
Price vs 200-day SMA	-35%
Price vs 50-day SMA	-9.59%
Relative volume	0.81
RSI	48.42
Sharpe ratio	-0.36
Sharpe ratio (3Y)	0.32
Sharpe ratio (5Y)	-0.13
Sortino ratio	-0.45
Sortino ratio (3Y)	0.64
Sortino ratio (5Y)	-0.16
Volume	388.8K
Weekly RSI	40.29
YTD price change	-41.56%
YTD total return	-41.56%

Metric

Value

150-day SMA

$0.98

1D price change

-0.87%

1M price change

-9.42%

1M total return

-9.42%

1W price change

13.91%

1W total return

13.91%

1Y price change

-49.79%

1Y return CAGR

-49.81%

1Y total return

-49.79%

20-day SMA

$0.70

200-day SMA

$1.04

3M price change

-13.27%

3M total return

-13.27%

3Y price change

-42.55%

3Y return CAGR

-16.87%

3Y total return

-42.55%

50-day SMA

$0.75

50-day SMA vs 200-day SMA

50under200

52-week high

$2.18

52-week high date

2025-11-03

52-week low

$0.54

52-week low date

2026-10-14

5Y price change

-96.14%

5Y return CAGR

-47.84%

5Y total return

-96.14%

6M price change

-54.5%

6M total return

-54.5%

All-time high

$309.60

All-time high date

2017-10-05

All-time low

$0.54

All-time low date

2026-10-14

Average true range (ATR)

$0.07

Average volume

477.2K

Beta (1Y)

1.73

Beta (2Y)

1.44

Beta (5Y)

1.36

Change from 52-week high

-67.98%

Change from 52-week low

29.25%

Change from all-time high

-99.78%

Change from all-time low

25.51%

Change from open

-0.87%

Day's gap

Dollar volume

$271,412

High price

$0.70

Low price

$0.67

Monthly RSI

36.43

Open price

$0.70

Position in 52-week range

82.67%

Premarket change

4.94%

Premarket close

$0.70

Premarket price

$0.74

Premarket volume

17.1K

Previous close

$0.70

Price vs 150-day SMA

-30.59%

Price vs 20-day SMA

-2.6%

Price vs 200-day SMA

-35%

Price vs 50-day SMA

-9.59%

Relative volume

0.81

RSI

48.42

Sharpe ratio

-0.36

Sharpe ratio (3Y)

0.32

Sharpe ratio (5Y)

-0.13

Sortino ratio

-0.45

Sortino ratio (3Y)

0.64

Sortino ratio (5Y)

-0.16

Volume

388.8K

Weekly RSI

40.29

YTD price change

-41.56%

YTD total return

-41.56%

Metric	Value
Float	66.1M
Float percentage	76.63%
Shares change (QoQ)	205.88%
Shares change (YoY)	283.2%
Shares held by insiders	6.02%
Shares held by institutions	36.37%
Shares outstanding	86.3M
Short % of float	0.99%
Short % of shares	0.75%
Short ratio	1.7 days

Metric

Value

Float

66.1M

Float percentage

76.63%

Shares change (QoQ)

205.88%

Shares change (YoY)

283.2%

Shares held by insiders

6.02%

Shares held by institutions

36.37%

Shares outstanding

86.3M

Short % of float

0.99%

Short % of shares

0.75%

Short ratio

1.7 days

Rein Therapeutics Inc. (RNTX)

Price

Financial snapshot

Fair-value bridge

Latest news · RNTX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All RNTX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on RNTX

Frequently asked questions